The U.S. Food and Drug Administration (FDA) is conducting market research to identify qualified sources for the replacement, maintenance, and program support of Automated External Defibrillators (AEDs) across FDA facilities nationwide. The requirement includes AED unit delivery and installation, preventive maintenance, CPR/AED training, and centralized program oversight for approximately 400 devices deployed across 87 cities.
Interested vendors should review the attached documents for further details:
Attachment A – Performance Work Statement (PWS)
Attachment B – Questions for Sources Sought Notice
Attachment C – Sources Sought Notice (SSN)
Vendors are encouraged to respond to the questions in Attachment B and submit capability statements in accordance with Attachment C.
